Resources
The resources on this page are available for use by the pharmaceutical industry, healthcare professionals (HCPs) and healthcare organisations (HCOs) to help them understand how Disclosure UK works.
Videos: Professional opinions of Disclosure UK.
In May 2016 we held a live panel debate on transparency in the pharmaceutical industry and payments made to healthcare professionals in the UK. Gathering some of the key thinkers on the subject at the headquarters of the Guardian in London we looked at the challenges and more importantly the opportunities this provides pharmaceutical companies.
Below are two videos capturing the perspectives of some of those who joined us on the night.
Clearly this is incredibly topical, we have the whole subject of conflicts of interest, and who pays whom and what they get for it has been of massive interest to journalists like me for a very long time. And it's very interesting to see developments, not only in the pharmaceutical industry but many other areas as well and within medicine and healthcare.
The ABPI Code of Practice hasn't been a static thing it has developed and grown, and the disclosing of payments to doctors and nurses and clinical professionals was a big, an important step, and the creation of a searchable database is a powerful and important step. I don't think anyone thinks it's the last word, but these are really tangible and important leadership moments that are changing the culture in the industry internationally, Really it's an opportunity for us to disclose not only on the issues of payments but really why those payments happen so what are the participations when the collaboration that we're involved with, with, with doctors and nurses and patients and really excited to do that because if we think this is fundamentals to the way we drive innovation in medicine.
Clearly this is incredibly topical, we have the whole subject of conflicts of interest, and who pays whom and what they get for it has been of massive interest to journalists like me for a very long time. And it's very interesting to see developments, not only in the pharmaceutical industry but many other areas as well and within medicine and healthcare.
The ABPI Code of Practice hasn't been a static thing it has developed and grown, and the disclosing of payments to doctors and nurses and clinical professionals was a big, an important step, and the creation of a searchable database is a powerful and important step. I don't think anyone thinks it's the last word, but these are really tangible and important leadership moments that are changing the culture in the industry internationally, Really it's an opportunity for us to disclose not only on the issues of payments but really why those payments happen so what are the participations when the collaboration that we're involved with, with, with doctors and nurses and patients and really excited to do that because if we think this is fundamentals to the way we drive innovation in medicine.
Video transcript
Clearly this is incredibly topical, we have the whole subject of conflicts of interest, and who pays whom and what they get for it has been of massive interest to journalists like me for a very long time. And it's very interesting to see developments, not only in the pharmaceutical industry but many other areas as well and within medicine and healthcare.
The ABPI Code of Practice hasn't been a static thing it has developed and grown, and the disclosing of payments to doctors and nurses and clinical professionals was a big, an important step, and the creation of a searchable database is a powerful and important step. I don't think anyone thinks it's the last word, but these are really tangible and important leadership moments that are changing the culture in the industry internationally, Really it's an opportunity for us to disclose not only on the issues of payments but really why those payments happen so what are the participations when the collaboration that we're involved with, with, with doctors and nurses and patients and really excited to do that because if we think this is fundamentals to the way we drive innovation in medicine.
Video transcript
Clearly this is incredibly topical, we have the whole subject of conflicts of interest, and who pays whom and what they get for it has been of massive interest to journalists like me for a very long time. And it's very interesting to see developments, not only in the pharmaceutical industry but many other areas as well and within medicine and healthcare.
The ABPI Code of Practice hasn't been a static thing it has developed and grown, and the disclosing of payments to doctors and nurses and clinical professionals was a big, an important step, and the creation of a searchable database is a powerful and important step. I don't think anyone thinks it's the last word, but these are really tangible and important leadership moments that are changing the culture in the industry internationally, Really it's an opportunity for us to disclose not only on the issues of payments but really why those payments happen so what are the participations when the collaboration that we're involved with, with, with doctors and nurses and patients and really excited to do that because if we think this is fundamentals to the way we drive innovation in medicine.
In May 2016 we held a live panel debate on transparency in the pharmaceutical industry and payments made to healthcare professionals in the UK.
Disclosure UK publications
Last modified: 20 September 2023
Last reviewed: 20 September 2023